The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 18640680)

Published in Atherosclerosis on June 20, 2008

Authors

Jeffrey W Stephens1, Manish P Khanolkar, Stephen C Bain

Author Affiliations

1: Department of Diabetes & Endocrinology, Morriston Hospital, Swansea SA6 6NL, UK. J.W.Stephens@Swansea.ac.uk

Articles citing this

Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol (2009) 4.58

Retracted Alpha-lipoic acid supplementation and diabetes. Nutr Rev (2008) 1.86

Diabetic nephropathy and antioxidants. J Nephropathol (2013) 1.80

Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51

Effects of Lipoic Acid Supplementation on Activities of Cyclooxygenases and Levels of Prostaglandins E2 and F2α Metabolites, in the Offspring of Rats with Streptozotocin-Induced Diabetes. J Diabetes Res (2016) 1.39

The isoprostanes--25 years later. Biochim Biophys Acta (2014) 1.11

Dietary patterns are associated with plasma F₂-isoprostanes in an observational cohort study of adults. Free Radic Biol Med (2012) 1.08

NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol (2011) 1.08

Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest Ophthalmol Vis Sci (2011) 1.06

LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia (2011) 0.89

Increased lipid peroxidation in LDL from type-2 diabetic patients. Lipids (2010) 0.89

Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta (2011) 0.89

Short (GT) ( n ) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress. Cell Stress Chaperones (2011) 0.86

White Blood Cells, Neutrophils, and Reactive Oxygen Metabolites among Asymptomatic Subjects. Int J Prev Med (2012) 0.85

An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study. Drug Metab Dispos (2013) 0.85

Correlation Between High-sensitivity C-reactive Protein and Reactive Oxygen Metabolites During A One-year Period Among Asymptomatic Subjects. J Clin Med Res (2012) 0.83

Association of the superoxide dismutase (V16A) and catalase (C262T) genetic polymorphisms with the clinical outcome of patients with acute paraquat intoxication. Korean J Intern Med (2010) 0.82

Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective. Biomarkers (2013) 0.81

Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data. BMC Med (2015) 0.81

Associations of self-reported smoking, cotinine levels and epigenetic smoking indicators with oxidative stress among older adults: a population-based study. Eur J Epidemiol (2017) 0.80

Contribution of oxidative stress to endothelial dysfunction in hereditary hemorrhagic telangiectasia. Front Genet (2015) 0.80

Orally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemia-reperfusion. Nutrients (2014) 0.80

Multivitamin mineral supplementation in patients with chronic fatigue syndrome. Med Sci Monit (2014) 0.80

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients. Int J Prev Med (2012) 0.80

Explosive type of moderate-resistance training induces functional, cardiovascular, and molecular adaptations in the elderly. Age (Dordr) (2013) 0.79

Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats. Biomed Res Int (2015) 0.78

Correlation between reactive oxygen metabolites & atherosclerotic risk factors in patients with type 2 diabetes mellitus. Indian J Med Res (2013) 0.78

Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation (2017) 0.78

Zebrafish models for ectopic mineralization disorders: practical issues from morpholino design to post-injection observations. Front Genet (2013) 0.77

Phenolic Rich Extract from Clinacanthus nutans Attenuates Hyperlipidemia-Associated Oxidative Stress in Rats. Oxid Med Cell Longev (2016) 0.77

Association of Glutathione-S-Transferase (GSTM1 and GSTT1) and FTO Gene Polymorphisms with Type 2 Diabetes Mellitus Cases in Northern India. Balkan J Med Genet (2014) 0.77

The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects. J Clin Med Res (2012) 0.76

Antiglycation, antioxidant and toxicological potential of polyphenol extracts of alligator pepper, ginger and nutmeg from Nigeria. Asian Pac J Trop Biomed (2012) 0.76

DNA methylation patterns associated with oxidative stress in an ageing population. BMC Med Genomics (2016) 0.75

The Janus Head of Oxidative Stress in Metabolic Diseases and During Physical Exercise. Curr Diab Rep (2017) 0.75

Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population. Exp Diabetes Res (2012) 0.75

The effect of omega-3 supplements on antioxidant capacity in patients with type 2 diabetes. Int J Prev Med (2013) 0.75

Elevated plasma F2-isoprostane levels in schizophrenia. Schizophr Res (2016) 0.75

Ameliorative Effect of Zinc Oxide Nanoparticles on Antioxidants and Sperm Characteristics in Streptozotocin-Induced Diabetic Rat Testes. Biomed Res Int (2015) 0.75

Effects of Omega-3 Fatty Acids Supplement on Antioxidant Enzymes Activity in Type 2 Diabetic Patients. Iran J Public Health (2016) 0.75

Articles by these authors

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med (2004) 6.21

Safety and side effects of the insulin analogues. Expert Opin Drug Saf (2006) 1.94

New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension. J Clin Endocrinol Metab (2013) 1.77

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets. Diabetes Care (2012) 1.73

Novel treatments for type 2 diabetes. Br J Gen Pract (2011) 1.38

A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci (2011) 0.97

Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes. J Sports Sci (2010) 0.95

Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis (2008) 0.94

Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care (2013) 0.92

Gene discovery in diabetic nephropathy. Curr Diab Rep (2007) 0.90

Comment on: Polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care 2011;34:262-267. Diabetes Care (2011) 0.89

One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target. J Diabetes Complications (2013) 0.86

Heart rate prescribed walking training improves cardiorespiratory fitness but not glycaemic control in people with type 2 diabetes. J Sports Sci (2010) 0.84

Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. Eur Heart J (2009) 0.81

Isomaltulose Improves Postexercise Glycemia by Reducing CHO Oxidation in T1DM. Med Sci Sports Exerc (2011) 0.81

Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial. Nephrol Dial Transplant (2011) 0.81

Safety and adverse effects associated with GLP-1 analogues. Expert Opin Drug Saf (2007) 0.81

Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy. Eur J Endocrinol (2002) 0.80

A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment. Drug Des Devel Ther (2013) 0.79

Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome. BMC Res Notes (2014) 0.78

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2010) 0.78

Nausea and vomiting due to insulin glargine in patient with type 1 diabetes mellitus. BMJ (2005) 0.78

Isomaltulose improves glycemia and maintains run performance in type 1 diabetes. Med Sci Sports Exerc (2012) 0.78

Cost-effective strategies in the prevention of diabetic nephropathy. Pharmacoeconomics (2004) 0.77

Are blood pressure levels taken during a secondary care diabetic clinic likely to be higher than when measured in primary care? Prim Care Diabetes (2009) 0.76

Improved end-stage high-intensity performance but similar glycemic responses after waxy barley starch ingestion compared to dextrose in type 1 diabetes. J Sports Med Phys Fitness (2015) 0.76

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial. J Hypertens (2016) 0.76

Safety and side effects of the insulin analogues. Expert Opin Drug Saf (2006) 0.75

Total antioxidant status before and after bariatric surgery for type 2 diabetes mellitus. Metabolism (2009) 0.75

Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues. Expert Opin Drug Saf (2007) 0.75